Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 77 Financial resources 213

1 The Con­fed­er­a­tion and the can­tons may al­loc­ate an in­terest-free en­dow­ment fund to the Agency.

2 The Agency shall fin­ance its ex­pendit­ure, in par­tic­u­lar, from:

a.214
fed­er­al re­mu­ner­a­tion for tasks re­ferred to in Art­icle 69 para­graph 1, where these are not covered by charges and fees;
b.
charges and fees re­ferred to in Art­icle 65;
c.
charges for ser­vices provided to oth­er au­thor­it­ies and in­ter­na­tion­al or­gan­isa­tions re­ferred to in Art­icle 69 para­graph 2.

2bis The fol­low­ing tasks and activ­it­ies of the Agency shall be fully fin­anced from fed­er­al re­mu­ner­a­tion:

a.
le­gis­la­tion;
b.
en­force­ment of crim­in­al pro­vi­sions;
c.
sur­veil­lance of med­ic­al devices.215

3 The task-spe­cif­ic use of the funds re­ferred to in para­graph 2 let­ters a and b and the ad­just­ments to be made in the event of over- or un­der­fin­an­cing of the tasks and activ­it­ies re­ferred to in para­graph 2bis shall be de­term­ined with­in the frame­work of the ap­prov­al of stra­tegic ob­ject­ives.216

4The fines and in­come from sanc­tions shall go to the Con­fed­er­a­tion.

213 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

214 Amended by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

215 In­ser­ted by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

216 Amended by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden